학술논문

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
Document Type
Article
Source
In The Lancet 7-13 January 2023 401(10370):25-37
Subject
Primary Research
Articles
Language
ISSN
0140-6736